TOXYLACT: a04 drugs for the treatment of nausea and vomiting

The first professional lActological database in the word

This web page content presents ATC A04 as “Antiemetics and antinauseants” used for nausea and vomiting of diverse origin and lists representative medicinal products marketed in Bulgaria.medpedia.framar

ATC A04 overview

The ATC main group A04 comprises antiemetic and antinauseant medicines acting on the vomiting reflex and on peripheral gastrointestinal mechanisms to prevent or treat nausea and vomiting. These symptoms arise from stimulation of the vomiting center in the medulla, which receives afferent signals from the vestibular apparatus, limbic system and spinal cord.medpedia.framar

Pharmacological subclasses and mechanisms

ATC A04 is subdivided mainly into A04A “Antiemetics and antinauseants”, which includes several pharmacological families such as 5‑HT3 receptor antagonists (e.g. ondansetron), H1‑antihistamines (e.g. dimenhydrinate) and various other agents. These drugs act through blockade of central and peripheral receptors in the chemoreceptor trigger zone, vomiting center, vestibular nuclei or gastrointestinal tract, thereby attenuating emetogenic stimuli from motion, drugs, toxins, pregnancy and systemic disease.medpedia.framar

Clinical indications (general)

Medicines in class A04 are indicated for prevention and treatment of nausea and vomiting associated with gastrointestinal disorders (gastritis, gastroenteritis, peptic ulcer disease), infections, pregnancy, migraine and neoplastic disease, as well as motion sickness. They are also widely used to control emesis induced by cytotoxic chemotherapy, radiotherapy and postoperative anaesthesia, often as part of multimodal antiemetic regimens.medpedia.framar

Toxicological profile

From a toxicological perspective, A04 agents differ substantially depending on their receptor profile and chemical class, but share risks related to CNS effects, cardiovascular toxicity and interactions with other drugs that also influence neurotransmission or cardiac conduction. Overdose or inappropriate use may result in excessive sedation, extrapyramidal reactions, arrhythmias (including QT prolongation for some agents), anticholinergic toxicity, metabolic disturbances and, rarely, severe hypersensitivity reactions.medpedia.framar

Lactation safety considerations

In lactation, risk assessment for A04 medicines must balance maternal benefit against potential exposure of the breastfed infant to neuroactive substances capable of altering central or peripheral neurotransmission. Short‑term, low‑dose use of certain agents with favourable pharmacokinetics (low oral bioavailability in the infant, limited milk penetration) is generally preferred, while drugs with marked sedative, cardiotoxic or serotonergic effects require cautious, individualized evaluation and monitoring of the infant for feeding difficulties, unusual drowsiness or irritability.medpedia.framar

Representative agents and formulations

The web page lists Bulgarian‑marketed products containing typical A04 active substances, including ondansetron (parenteral and oral formulations such as Zofran and Accord generics) and dimenhydrinate tablets for motion sickness. It also shows related or associated products used in the management of gastrointestinal discomfort and vomiting, such as Vomitus Heel oral drops and suppositories, alongside several sodium citrate‑containing preparations that are catalogued under the same active‑ingredient index.medpedia.framar

Recent Posts

July 24

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

July 18

Abdominal Compartment Syndrome

While the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 14

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.